Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.
When people first hear about NK cell therapy, they often ask a more basic question: what are NK cells, and what do they actually do in the body? Understanding the underlying biology makes it easier to talk with your doctor and to judge what a therapy can and cannot be expected to do. This article explains NK cells and a concept called immune surveillance in plain language, then connects that science to the NK cell therapy offered at Grand Green Osaka Umekita Clinic in Osaka.
The short answer
NK (natural killer) cells are a type of white blood cell that belongs to the innate immune system. They circulate in the blood and are able to recognize and attack abnormal cells, including some cancer cells and virus-infected cells, without needing to be trained beforehand. Immune surveillance is the idea that the immune system continually checks the body for abnormal cells and removes many of them before they cause problems. NK cell therapy is built on this idea: it aims to return a larger number of activated NK cells to the body. It is not a guaranteed treatment, and it is not a replacement for standard cancer care.
What are NK cells?
NK cells are a kind of lymphocyte. Unlike T cells, which must first learn to recognize a specific target, NK cells can act on their own. They check the surface of other cells for signals that suggest something is wrong. A healthy cell usually carries markers that tell NK cells to stand down, while a stressed, infected or abnormal cell may lose those markers or display warning signals instead. When the balance tips toward warning, an NK cell can release molecules such as perforin that damage the target cell.
Because they respond quickly, NK cells are often described as part of the first line of immune defense. They also communicate with other immune cells, which helps shape the wider immune response. Researchers continue to study how NK cells behave in different tumor environments, and the picture is still developing.
What is immune surveillance?
Even in healthy people, abnormal cells that could potentially develop into cancer are thought to arise from time to time. In most cases they never become a disease, in part because immune cells, including NK cells, find and remove them. This ongoing monitoring is called immune surveillance. It is a useful way to picture how the body protects itself, although the details are complex and vary from person to person.
Cancer can develop when abnormal cells escape this monitoring. Some tumors develop ways to hide from immune cells or to suppress their activity. Scientists sometimes describe this as immune evasion. It is one reason why researchers are interested in approaches that support or strengthen immune function, and also one reason why such approaches do not work the same way for everyone.
Why NK cell activity can change
NK cell activity is known to vary between individuals and over time. It is generally reported to decline with age, and it may also be affected by chronic stress and by the presence of cancer itself. Some cancer treatments can also influence immune function, which is one reason your oncology team’s overall plan matters.
It is important not to over-interpret this. A lower or higher measured activity level does not by itself tell you whether you will develop or recover from cancer, and the relationship between laboratory measurements and real-world outcomes is not simple. If you are curious about immune testing, ask a doctor what a given test can and cannot tell you.
How NK cell therapy relates to this science
In NK cell therapy, NK cells are obtained from your own blood through a standard blood draw. They are then activated and expanded at a specialized cell processing facility and returned to your body by intravenous infusion. The aim is to increase the number and activity of NK cells available to the body. Because the cells come from you, this is called an autologous therapy, and the risk of rejection is considered low. Temporary reactions such as fever or fatigue can occur, and your doctor should explain the possible risks and side effects before you decide.
Treatment of this kind is intended to be considered alongside, not instead of, standard cancer treatment such as surgery, chemotherapy or radiation therapy. It is also sometimes sought by people who want to maintain immune function after treatment. Whether it is appropriate for you depends on your diagnosis, your stage, your current treatment and your overall health, which only a doctor who has examined you can judge.
It is also honest to say that the evidence for immune cell therapies varies by cancer type and by how the cells are prepared. Laboratory findings about NK cells are encouraging as basic science, but they do not guarantee clinical benefit for an individual patient. Asking a clinic how it approaches the evidence is a reasonable thing to do.
Practical points for patients considering care in Osaka
In Japan, NK cell therapy is provided as a self-pay (non-insured) treatment, which means it is not covered by national health insurance. It is offered under the Act on the Safety of Regenerative Medicine, which requires a treatment plan to be reviewed by a certified committee and submitted to the Ministry of Health, Labour and Welfare and requires cells to be handled at licensed facilities. Costs, the number of treatments, risks, side effects and eligibility should all be confirmed with a doctor during a consultation.
If you live in Osaka or are considering traveling for care, Grand Green Osaka Umekita Clinic, located in the Umeda area, provides an information page for international patients so that you can review the basics in advance. Before a consultation, it can help to prepare the following:
- Your diagnosis, stage and a summary of treatments so far, ideally in writing
- The name of the doctor currently treating you, and whether they are aware of your plans
- Your questions about evidence, risks, side effects and expected time commitment
- A list of your current medications and any known allergies
- Questions about total costs, since the therapy is not covered by insurance
Summary
NK cells are innate immune cells that help the body watch for abnormal cells, a process known as immune surveillance. Their activity can change with age, stress and illness, and NK cell therapy aims to return a greater number of activated cells to the body. It is a self-pay option provided under Japan’s regenerative medicine framework, and it is meant to be discussed alongside standard treatment, not as a substitute. Its benefits cannot be promised, and the right decision depends on your individual situation. Please consult a doctor to talk through your diagnosis, the evidence, the risks and the costs before making a decision.
- NK cells watch the bodyInnate immune cells
- Activity can changeAge, stress, illness
- Own cells, infusedBlood draw, then IV
- Benefits not promisedAsk about risks
This diagram is a conceptual summary of the article
References
- PubMed: Tumor-Infiltrating Natural Killer Cells. (2021)
- PubMed: Human natural killer cells. (2008)
- PubMed: Natural Killer Cells: Development, Maturation, and Clinical Utilization. (2018)
- PubMed: Reprogramming Immune Cells for Enhanced Cancer Immunotherapy: Targets and Strategies. (2021)
- PubMed: Exploiting innate immunity for cancer immunotherapy. (2023)
- PMC: Oncogenic stress sensed by the immune system: role of natural killer cell receptors. (2009)
- PMC: Is the MAPK ERK5 the nexus from FAO to NK cell-mediated metastasis immune surveillance? (2025)
- PMC: A systematic scoping review on natural killer cell function in colorectal cancer. (2021)
- MHLW (Japan): Regenerative Medicine — Ministry of Health, Labour and Welfare, Japan
Supervising Physician
Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic
Hidenori Shimada
Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.
* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.